Metrika

  • citati u SCIndeksu: 0
  • citati u CrossRef-u:0
  • citati u Google Scholaru:[]
  • posete u poslednjih 30 dana:8
  • preuzimanja u poslednjih 30 dana:5

Sadržaj

članak: 6 od 41  
Back povratak na rezultate
2017, vol. 74, br. 6, str. 550-555
Koncentracije B-tipa natriuretskog peptida i N-terminalnog prohormon B-tipa natriuretskog peptida u krvi kao pokazatelji dijastolne funkcije leve komore kod bolesnika sa hroničnom bubrežnom insuficijencijom
aVojnomedicinska akademija, Klinika za nefrologiju, Beograd
bUniverzitet odbrane, Medicinski fakultet Vojnomedicinske akademije, Beograd + Vojnomedicinska akademija, Klinika za kardiologiju, Beograd
cUniverzitet odbrane, Medicinski fakultet Vojnomedicinske akademije, Beograd + Vojnomedicinska akademija, Nacionalni centar za kontrolu trovanja, Beograd
dVojnomedicinska akademija, Klinika za nefrologiju, Beograd + Univerzitet odbrane, Medicinski fakultet Vojnomedicinske akademije, Beograd
eUniverzitet odbrane, Medicinski fakultet Vojnomedicinske akademije, Beograd + Vojnomedicinska akademija, Klinika za anesteziologiju i intenzivnu terapiju, Beograd
fInstitute for Health Protection of the Ministry of Interior, Department of Internal Medicine, Belgrade
gKlinički centar Kragujevac, Klinika za urologiju, nefrologiju i dijalizu
hUniverzitet odbrane, Medicinski fakultet Vojnomedicinske akademije, Beograd + Vojnomedicinska akademija, Institut za medicinsku biohemiju, Beograd

e-adresadrmilicapetrovic@gmail.com
Sažetak
Uvod/Cilj. Bolesnici sa hroničnom bubrežnom insuficijencijom (HBI) imaju povećan kardiovaskularni morbiditet i mortalitet. Nije poznato koji biomarkeri najbolje opisuju stepen dijastolne disfunkcije kod bolesnika sa HBI. Cilj ove studije bio je da se utvrdi povezanost koncentracije B-tipa natriuretskog peptida (BNP), N-terminalnog prohormon moždanog natriuretskog peptida (NTproBNP) i dijastolne disfunkcije leve komore (DD-LV) sa stepenom HBI. Metode. U studiju je bilo uključeno 100 odraslih bolesnika sa hroničnom bubrežnom bolesti koji nisu imali srčane i cerebralne incidente i nisu započeli aktivno lečenje HBI. Prema stepenu HBI bolesnike smo podelili u dve grupe: G1 (umereni stepen), glomerularna filtracija (GFR) ≥ 30 mL/min/1,73 m2, i G2 (teži stepen), GFR < 30 mL/min/1,73 m2. U krvi su određene koncentracije BNP i NTproBNP, a dopler ehokardiografskim merenjem procenjena je dijastolna disfunkcija leve komore (DD-LV). Prema stepenu DD-LV bolesnici su podeljeni u dve grupe: DD-LV1 (blaga dijastolna disfunkcija) i DD-LV2 (teška dijastolna disfunkcija). Prema stepenu HBI i DD-LV bolesnici su podeljeni u četiri grupe: I (G1, DD-LV1), II (G1, DD-LV2), III (G2, DD-LV1) i IV (G2, DD-LV2). Rezultati. Utvrđena je visokoznačajna statistička korelacija BNP i NTproBNP sa GFR (p < 0,001), a DD-LV sa BNP (p < 0,023), odnosno NTproBNP (p = 0,035). Registrovane su statistički značajno više koncentracije BNP kod bolesnika sa DD LV2, nego kod bolesnika sa G2 (p < 0,001). Za razliku od BNP, kod bolesnika sa disfunkcijom DD-LV1, ali i onih sa disfunkcijom DD-LV2, registrovane su statistički značajno veće koncentracije NTproBNP kod bolesnika sa G2 (DD-LV1: p = 0,006; DD-LV2: p < 0,001). Zaključak. Biomarkeri BNP i NTproBNP nisu najbolji prediktori u proceni dijastolne disfunkcije jer su u korelaciji sa stepenom hronične bubrežne insuficijencije.
Reference
Briasoulis, A., Bakris, G.L. (2013) Chronic Kidney Disease as a Coronary Artery Disease Risk Equivalent. Current Cardiology Reports, 15(3):
Bruch, C., Rothenburger, M., Gotzmann, M., Wichter, T., Scheld, H.H., Breithardt, G., Gradaus, R. (2007) Chronic kidney disease in patients with chronic heart failure - Impact on intracardiac conduction, diastolic function and prognosis. International Journal of Cardiology, 118(3): 375-380
Chobanian, A.V. (2003) The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureThe JNC 7 Report. JAMA, 289(19): 2560
Coresh, J., Astor, B.C., Greene, T., Eknoyan, G., Levey, A.S. (2003) Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third national health and nutrition examination survey. American Journal of Kidney Diseases, 41(1): 1-12
Fathi, R., Isbel, N., Haluska, B., Case, C., Johnson, D.W., Marwick, T.H. (2003) Correlates of subclinical left ventricular dysfunction in ESRD. American journal of kidney diseases, 41(5): 1016-25
Foley, R.N., Parfrey, P.S., Sarnak, M.J. (1998) Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol, 9(12 Suppl): S16−23
Harada, M., Hara, F., Yamazaki, J. (2010) Correlation between plasma B-type natriuretic peptide levels and left ventricular diastolic function using color kinetic imaging. Journal of Cardiology, 56(1): 91-96
Herzog, C.A., Asinger, R.W., Berger, A.K., Charytan, D.M., Díez, J., Hart, R.G., Eckardt, K., Kasiske, B.L., McCullough, P.A., Passman, R.S., DeLoach, S.S., Pun, P.H., Ritz, E. (2011) Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney International, 80(6): 572-586
Kim, J., Kim, S.G., Kim, M., Kim, S.E., Kim, S.J., Kim, H.J., Song, Y.R. (2012) Left Ventricular Diastolic Dysfunction as a Predictor of Rapid Decline of Residual Renal Function in Patients with Peritoneal Dialysis. Journal of the American Society of Echocardiography, 25(4): 411-420
Lai, S., Dimko, M., Galani, A., Coppola, B., Innico, G., Frassetti, N., Mazzei, E.D., Mariotti, A. (2015) Early markers of cardiovascular risk in chronic kidney disease. Renal Failure, 37(2): 254-261
Levey, A.S., Stevens, L.A., Schmid, C.H., Zhang, Y.(Lucy), Castro, A.F., Feldman, H.I., Kusek, J.W., Eggers, P., Van, L.F., Greene, T., Coresh, J. (2009) A New Equation to Estimate Glomerular Filtration Rate. Annals of Internal Medicine, 150(9): 604
Levin, A. (2003) Clinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysis. Semin Dial, 16(2): 101-5
Lubien, E., DeMaria, A., Krishnaswamy, P., Clopton, P., Koon, J., Kazanegra, R., Gardetto, N., Wanner, E., Maisel, A.S. (2002) Utility of B-natriuretic peptide in detecting diastolic dysfunction: Comparison with Doppler velocity recordings. Circulation, 105(5): 595-601
Luczak, M., Formanowicz, D., Pawliczak, E., Wanic-Kossowska, M., Wykretowicz, A., Figlerowicz, M. (2011) Chronic kidney disease-related atherosclerosis - proteomic studies of blood plasma. Proteome Science, 9(1): 25
Manjunath, G., Tighiouart, H., Coresh, J., Macleod, B., Salem, D.N., Griffith, J.L., Levey, A.S., Sarnak, M.J. (2003) Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. Kidney International, 63(3): 1121-1129
Manjunath, G., Tighiouart, H., Ibrahim, H., MacLeod, B., Salem, D.N., Griffith, J.L., Coresh, J., Levey, A.S., Sarnak, M.J. (2003) Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. Journal of the American College of Cardiology, 41(1): 47-55
Muntner, P., He, J., Hamm, L., Loria, C., Whelton, P.K. (2002) Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol, 13(3): 745-53
Naidu, S.S., Selzer, F., Jacobs, A., Faxon, D., Marks, D.S., Johnston, J., Detre, K., Wilensky, R.L. (2003) Renal insufficiency is an independent predictor of mortality after percutaneous coronary intervention. Am J Cardiol, 92(10): 1160-4
Otsuka, T., Suzuki, M., Yoshikawa, H., Sugi, K. (2009) Left ventricular diastolic dysfunction in the early stage of chronic kidney disease. Journal of Cardiology, 54(2): 199-204
Paulus, W.J., Tschöpe, C., Sanderson, J.E., Rusconi, C., Flachskampf, F.A., Rademakers, F.E., Marino, P., Smiseth, O.A., de Keulenaer, G., Leite-Moreira, A.F., i dr. (2007) How to diagnose diastolic heart failure: A consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the heart failure and echocardiography associations of the european society of cardiology. European heart journal, 28(20): 2539-50
Reddan, D. N. (2003) Chronic Kidney Disease, Mortality, and Treatment Strategies among Patients with Clinically Significant Coronary Artery Disease. Journal of the American Society of Nephrology, 14(9): 2373-2380
Shah, A.M., Lam, C.S.P., Cheng, S., Verma, A., Desai, A.S., Rocha, R.A., Hilkert, R., Izzo, J., Oparil, S., Pitt, B., Thomas, J.D., Zile, M.R., Aurigemma, G.P., Solomon, S.D. (2011) The relationship between renal impairment and left ventricular structure, function, and ventricular-arterial interaction in hypertension. Journal of hypertension, 29(9): 1829-36
Sidhu, M.S., Dellsperger, K.C. (2010) Cardivascular problems in dialysis patients: Impact on survival. Adv Perit Dial, 26: 47-52
Verma, A., Anavekar, N.S., Meris, A., Thune, J.J., Arnold, J. M.O., Ghali, J.K., Velazquez, E.J., McMurray, J.J.V., Pfeffer, M.A., Solomon, S.D. (2007) The Relationship Between Renal Function and Cardiac Structure, Function, and Prognosis After Myocardial Infarction. Journal of the American College of Cardiology, 50(13): 1238-1245
Victor, B.M., Barron, J.T. (2010) Diastolic Heart Failure Versus Diastolic Dysfunction: Difference in Renal Function. Clinical Cardiology, 33(12): 770-774
Yang, Y., Wang, Y., Shi, Z., Zhu, D., Gao, P. (2013) Association of E/E′ and NT-proBNP with Renal Function in Patients with Essential Hypertension. PLoS ONE, 8(1): e54513
 

O članku

jezik rada: engleski
vrsta rada: izvorni naučni članak
DOI: 10.2298/VSP151019079P
objavljen u SCIndeksu: 01.06.2017.
metod recenzije: dvostruko anoniman
Creative Commons License 4.0

Povezani članci

Vojnosanitetski pregled (2005)
Natriuretski peptidi u kliničkoj praksi
Matunović Radomir, i dr.

Vojnosanitetski pregled (2018)
Promet i funkcija trombocita u završnom stadijumu hronične bubrežne insuficijencije
Filipov Predrag, i dr.

Timočki medicinski glasnik (2019)
Patofiziološki mehanizmi kardiovaskularnog oboljevanja u hroničnoj bubrežnoj bolesti i mogućnosti prevencije
Tirmenštajn-Janković Biserka

prikaži sve [17]